-
Product Insights
NewNet Present Value Model: Mereo Biopharma Group Plc’s Etigilimab
Empower your strategies with our Net Present Value Model: Mereo Biopharma Group Plc's Etigilimab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Evorpacept in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Evorpacept in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Evorpacept in Follicular Lymphoma Drug Details: Evorpacept is under development for the...
-
Product Insights
Osteogenesis Imperfecta – Drugs In Development, 2023
Global Markets Direct’s, ‘Osteogenesis Imperfecta - Drugs In Development, 2023’, provides an overview of the Osteogenesis Imperfecta pipeline landscape. The report provides comprehensive information on the therapeutics under development for Osteogenesis Imperfecta, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Bronchiolitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Bronchiolitis - Drugs In Development, 2023’, provides an overview of the Bronchiolitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bronchiolitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Secondary (Hypogonadotropic) Hypogonadism – Drugs In Development, 2023
Global Markets Direct’s, ‘Secondary (Hypogonadotropic) Hypogonadism - Drugs In Development, 2023’, provides an overview of the Secondary (Hypogonadotropic) Hypogonadism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Secondary (Hypogonadotropic) Hypogonadism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Germ Cell Tumors – Drugs In Development, 2023
Global Markets Direct’s, ‘Germ Cell Tumors - Drugs In Development, 2023’, provides an overview of the Germ Cell Tumors pipeline landscape. The report provides comprehensive information on the therapeutics under development for Germ Cell Tumors, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Male Hypogonadism – Drugs In Development, 2023
Global Markets Direct’s, ‘Male Hypogonadism - Drugs In Development, 2023’, provides an overview of the Male Hypogonadism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Male Hypogonadism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Bronchitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Bronchitis - Drugs In Development, 2023’, provides an overview of the Bronchitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bronchitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Alpha-1 Antitrypsin Deficiency (A1AD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Alpha-1 Antitrypsin Deficiency (A1AD) - Drugs In Development, 2023’, provides an overview of the Alpha-1 Antitrypsin Deficiency (A1AD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alpha-1 Antitrypsin Deficiency (A1AD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Anal Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Anal Cancer - Drugs In Development, 2023’, provides an overview of the Anal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...